KLRK1 and cancer: To evaluate the effect of NKG2D on the antitumor cytotoxicity of NK cells, NK cells expanded by the combination of the αCD16 mAb with IrAPs were cocultured with target cancer cells in the presence of a NKG2D-blocking antibody.